Ali Roghanian

2.6k total citations
32 papers, 1.5k citations indexed

About

Ali Roghanian is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ali Roghanian has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 15 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ali Roghanian's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Immune Cell Function and Interaction (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Ali Roghanian is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Immune Cell Function and Interaction (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Ali Roghanian collaborates with scholars based in United Kingdom, Netherlands and United States. Ali Roghanian's co-authors include Jean‐Michel Sallenave, Mark S. Cragg, Steven E. Williams, Stephen A. Beers, Martin J. Glennie, H.T. Claude Chan, C. Ian Mockridge, Ruth R. French, Sarah Howie and Paul M. Fitch and has published in prestigious journals such as Blood, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ali Roghanian

31 papers receiving 1.4k citations

Peers

Ali Roghanian

IMMUN

RNMI

MB

ONCOL

PRM

Marcin Okrój Poland

Tineke Cantaert Netherlands

Judith L. McKenzie New Zealand

M. Hadam Germany

Laurence Ménard United States

Robert F. Graziano United States

Y Hitoshi Japan

Sergio Arce United States

Sue Blackwell United States

Amanda Guth United States

Marcin Okrój Poland

Ali Roghanian

757 ×0.9

IMMUN

153 ×0.4

RNMI

394 ×1.0

MB

158 ×0.5

ONCOL

112 ×0.7

PRM

Citations per year, relative to Ali Roghanian Ali Roghanian (= 1×) peers Marcin Okrój

Countries citing papers authored by Ali Roghanian

Since Specialization

Citations

This map shows the geographic impact of Ali Roghanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Roghanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Roghanian more than expected).

Fields of papers citing papers by Ali Roghanian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Roghanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Roghanian. The network helps show where Ali Roghanian may publish in the future.

Co-authorship network of co-authors of Ali Roghanian

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Roghanian. A scholar is included among the top collaborators of Ali Roghanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Roghanian. Ali Roghanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Foxall, Russell B., Kerry L. Cox, Robert Oldham, et al.. (2024). CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis. PubMed. 5(1). ltaf029–ltaf029.

2.

Burns, Daniel, et al.. (2023). Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. Frontiers in Immunology. 14. 1176724–1176724. 23 indexed citations

3.

Frendéus, Björn, et al.. (2023). Human leukocyte immunoglobulin-like receptors in health and disease. Frontiers in Immunology. 14. 1282874–1282874. 23 indexed citations

4.

Roghanian, Ali, et al.. (2022). Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy. JCI Insight. 7(2). 25 indexed citations

5.

Roghanian, Ali, Robert Oldham, H.T. Claude Chan, et al.. (2022). FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms. Cell Reports. 40(3). 111099–111099. 16 indexed citations

6.

Roghanian, Ali, Guangan Hu, Christophe Fraser, et al.. (2019). Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression. Cancer Immunology Research. 7(11). 1876–1890. 29 indexed citations

7.

Roghanian, Ali, et al.. (2016). Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1. Journal of Leukocyte Biology. 100(4). 737–746. 11 indexed citations

8.

Dahal, Lekh N., Ali Roghanian, Stephen A. Beers, & Mark S. Cragg. (2015). FcγR requirements leading to successful immunotherapy. Immunological Reviews. 268(1). 104–122. 35 indexed citations

9.

Roghanian, Ali, Mark S. Cragg, & Björn Frendéus. (2015). Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapy. OncoImmunology. 5(2). e1069939–e1069939. 10 indexed citations

10.

White, Ann L., H.T. Claude Chan, Ruth R. French, et al.. (2014). Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies. Cancer Cell. 27(1). 138–148. 125 indexed citations

11.

Vaughan, Andrew, Ali Roghanian, & Mark S. Cragg. (2010). B cells—Masters of the immunoverse. The International Journal of Biochemistry & Cell Biology. 43(3). 280–285. 38 indexed citations

12.

Roghanian, Ali, Des C. Jones, Jogi V. Pattisapu, et al.. (2010). Filament-associated TSGA10 protein is expressed in professional antigen presenting cells and interacts with vimentin. Cellular Immunology. 265(2). 120–126. 10 indexed citations

13.

Jones, Des C., Ali Roghanian, D. Brown, et al.. (2009). Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. European Journal of Immunology. 39(11). 3195–3206. 35 indexed citations

14.

Roghanian, Ali & Jean‐Michel Sallenave. (2008). Neutrophil Elastase (NE) and NE Inhibitors: Canonical and Noncanonical Functions in Lung Chronic Inflammatory Diseases (Cystic Fibrosis and Chronic Obstructive Pulmonary Disease). Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(1). 125–144. 48 indexed citations

15.

Roghanian, Ali & Jean‐Michel Sallenave. (2008). Neutrophil Elastase (NE) and NE Inhibitors: Canonical and Noncanonical Functions in Lung Chronic Inflammatory Diseases (Cystic Fibrosis and Chronic Obstructive Pulmonary Disease). Journal of Aerosol Medicine. 0(0). 2861233976–20. 2 indexed citations

16.

Young, Neil T., et al.. (2007). The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood. 111(6). 3090–3096. 82 indexed citations

17.

Roghanian, Ali, Ellen Drost, William MacNee, Sarah Howie, & Jean‐Michel Sallenave. (2006). Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase. American Journal of Respiratory and Critical Care Medicine. 174(11). 1189–1198. 62 indexed citations

18.

Roghanian, Ali, et al.. (2006). The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity. American Journal of Respiratory Cell and Molecular Biology. 34(5). 634–642. 39 indexed citations

19.

Roghanian, Ali, Paul M. Fitch, Sarah Howie, & Jean‐Michel Sallenave. (2006). Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochemical Society Transactions. 34(2). 279–279. 56 indexed citations

20.

Roghanian, Ali, et al.. (2005). The Antimicrobial Antiproteinase Elafin Binds to Lipopolysaccharide and Modulates Macrophage Responses. American Journal of Respiratory Cell and Molecular Biology. 32(5). 443–452. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact